EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Q2 2023 Earnings Call Transcript August 2, 2023
EyePoint Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.52 EPS, expectations were $0.41.
Operator: Good morning. My name is [indiscernible] and I will be your conference operator today. At this time, I would like to welcome everyone to the EyePoint Pharmaceuticals Second Quarter 2023 Financial Results and Recent Corporate Development Conference Call. There will be a...
